Literature DB >> 16448740

Needle core length is a quality indicator of systematic transperineal prostate biopsy.

Vincenzo Ficarra1, Guido Martignoni, Giovanni Novella, Maria Angela Cerruto, Antonio Galfano, Giacomo Novara, Maurizio Pea, Walter Artibani.   

Abstract

OBJECTIVE: To analyse the length of needle cores sampled as a quality indicator in systematic transperineal prostate biopsy. We assessed the correlation of core length with the other clinical and topographic parameters.
MATERIAL AND METHODS: We prospectively evaluated data from 509 consecutive patients who underwent a first set of transrectal ultrasound-guided transperineal prostate biopsy for suspected prostate cancer. Fourteen cores were sampled from each patient. Needle cores were stretched and placed in tissue cassettes between two nylon meshes according to the pre-embedding methods of prostate needle biopsy specimens. For single biopsy core, the measurement of length (in millimetres) and any percentage of cancer in the biopsy specimen were reported.
RESULTS: The mean length of 7,126 analysed cores was 14.14+/-4.35mm. All cores were longer than 10mm. The mean length of needle cores sampled did not correlate with patient age, total prostate-specific antigen value, digital rectal examination, and prostate volume. The whole mean length of the six samples from the peripheral zone of the right lobe was higher than the mean corresponding value of the six samples from the left lobe peripheral zone (p<0.001). The transperineal approach allows a greater sampling of the prostate apex than of the midgland and prostate base (p<0.001).
CONCLUSIONS: The length of the needle cores sampled during transperineal prostate biopsy fulfils the parameters of quality required by pathologists for an appropriate evaluation of the biopsy specimen.

Entities:  

Mesh:

Year:  2006        PMID: 16448740     DOI: 10.1016/j.eururo.2005.12.057

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

Review 1.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

2.  Does length of prostate biopsy cores have an impact on diagnosis of prostate cancer?

Authors:  Müslüm Ergün; Ekrem İslamoğlu; Soner Yalçınkaya; Hüsnü Tokgöz; Murat Savaş
Journal:  Turk J Urol       Date:  2016-09

3.  Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.

Authors:  Erik Velez; Andriy Fedorov; Kemal Tuncali; Olutayo Olubiyi; Christopher B Allard; Adam S Kibel; Clare M Tempany
Journal:  Abdom Radiol (NY)       Date:  2017-08

4.  Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Authors:  Hasan Yılmaz; Ufuk Yavuz; Murat Üstüner; Seyfettin Çiftçi; Hikmet Yaşar; Bahar Müezzinoğlu; Ali Kemal Uslubaş; Özdal Dillioğlugil
Journal:  Turk J Urol       Date:  2017-07-31

5.  Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer.

Authors:  Hideki Takeshita; Noboru Numao; Toshiki Kijima; Minato Yokoyama; Junichiro Ishioka; Yoh Matsuoka; Fumitaka Koga; Kazutaka Saito; Hitoshi Masuda; Satoru Kawakami; Shinya Yamamoto; Junji Yonese; Yasuhisa Fujii; Kazunori Kihara
Journal:  Int Urol Nephrol       Date:  2013-03-26       Impact factor: 2.370

6.  Does needle calibre affect pain and complication rates in patients undergoing transperineal prostate biopsy? A prospective, randomized trial.

Authors:  Giovanni Saredi; Saredi Giovanni; Maria Chiara Sighinolfi; Francesco Fidanza; Fidanza Francesco; Stefano De Stefani; De Stefani Stefano; Salvatore Micali; Micali Salvatore; Paterlini Maurizio; Maurizio Paterlini; Roberto D'Amico; Giampaolo Bianchi; Bianchi Giampaolo
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

7.  Gleason underestimation is predicted by prostate biopsy core length.

Authors:  Leonardo O Reis; Brunno C F Sanches; Gustavo Borges de Mendonça; Daniel M Silva; Tiago Aguiar; Ocivaldo P Menezes; Athanase Billis
Journal:  World J Urol       Date:  2014-08-02       Impact factor: 4.226

8.  Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.

Authors:  J L Dominguez-Escrig; S R C McCracken; D Greene
Journal:  Prostate Cancer       Date:  2010-12-09

9.  Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy.

Authors:  Andrea Benedetto Galosi; Giovanni Muzzonigro; Vito Lacetera; Roberta Mazzucchelli
Journal:  Prostate Cancer       Date:  2011-07-27

10.  Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution.

Authors:  Carlo Andrea Bravi; Emily Vertosick; Amy Tin; Simone Scuderi; Giuseppe Fallara; Giuseppe Rosiello; Elio Mazzone; Marco Bandini; Giorgio Gandaglia; Nicola Fossati; Massimo Freschi; Rodolfo Montironi; Alberto Briganti; Francesco Montorsi; Andrew Vickers
Journal:  Eur Urol Oncol       Date:  2018-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.